Accurate and generalizable protein-ligand binding affinity prediction with geometric deep learning
Krinos Li, Xianglu Xiao, Zijun Zhong, Guang Yang* · 2025
Read Accurate and generalizable protein-ligand binding affinity prediction with geometric deep learning by Krinos Li, Xianglu Xiao, Zijun Zhong, Guang Yang* (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2504-16261.txt.
Introduction
Krinos Li, Xianglu Xiao, Zijun Zhong, and Guang Yang wrote this paper in two thousand twenty-five. It forecasts how strongly a drug-like molecule will bind to a protein, with a geometric deep learning method called IPBind.
Binding strength guides drug design, but past tools sag when the protein is new and unseen. IPBind leans on the push and pull between atoms in the bound and unbound states of the pair. On wide benchmark sets it scores well and holds up on fresh proteins. It also gives atom-level clues for each call. The work shows machine-learned atomic forces as a sound base for this gauge.
Catalog record
| CREATOR | Krinos Li, Xianglu Xiao, Zijun Zhong, Guang Yang* |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2504-16261
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Accurate and generalizable protein-ligand binding affinity prediction with geometric deep learning Krinos Li, Xianglu Xiao, Zijun Zhong, Guang Yang* Abstract Goal: Protein-ligand binding complexes are ubiquitous and essential to life. Protein-ligand binding affinity prediction (PLA) quantifies the binding strength between ligands and proteins, providing crucial insights for discovering and designing potential candidate ligands. While recent advances have been made in predicting protein-ligand complex structures, existing algorithms for interaction and affinity prediction suffer from a sharp decline in performance when handling ligands bound with novel unseen proteins. Methods: We propose IPBind, a geometric deep learning-based computational method, enabling robust predictions by leveraging interatomic potential between complex’s bound and unbound status. Results: Experimental results on widely used binding affinity prediction benchmarks demonstrate the effectiveness and universality of IPBind. Meanwhile, it provids atom-level insights into prediction. Conclusions : This work highlight the advantage of leveraging machine learning interatomic potential for predicting protein-ligand binding affinity. Impact Statement– This study extends state-of-the-art deep learning algorithms to applications in protein-ligand binding affinity prediction. This study has implications for enhancing the generalization capability of protein-ligand interactions prediction methods by interatomic potential modeling. I INTRODUCTION Figure 1: Overview of IPBind A. IPbind leverages the difference between bound and unbound status of protein-ligand to predict their binding affinity B. Workflow of IPBind. The initial protein-ligand complex were used to construct three atom-level graphs, after encoder module, atomic contribution of each graph will be summed up to predict the binding affinity between input protein and ligand. n: number of atoms in each molecule, d: number of representation dimensions. C. Radius edges creation D. Message passing layer. E. The prediction module of IPBind. Modern drug discovery is a protracted and costly endeavor, often spanning over a decade with expenditures exceeding billions of US dollars [ 1 ] . A critical bottleneck lies in identifying high-affinity ligands that bind tightly to target proteins, as binding affinity—quantified by the energy difference between unbound and bound states—serves as a pivotal indicator of therapeutic potential. Higher binding affinity reflects stronger stabilization of the bound complex relative to the separated components [ 2 , 3 ] . While experimental techniques like isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) remain gold standards, their high cost and less efficiency hinder large-scale precessing [ 4 ] . The advent of structure-based computational approaches has reshaped early-stage drug discovery by enabling rapid in silico prediction. These methods leverage 3D structural insights to rationally design ligands that complement target binding sites [ 5 , 6 ] . Among them, deep learning (DL) has emerged as a transformative tool, and achieved breakthroughs in predicting protein-ligand affinities [ 7 , 8 , 9 , 10 ] . Unlike conventional methods requiring handcrafted feature engineering, DL models enables autonomously extracting hierarchical representations from structural data and capturing intricate patterns. For example, protein-ligand complex can be represented as voxels, and employs 3D convolutional neural networks (CNN) to learn the relationship between spatial interactions and physicochemical properties [ 11 , 12 ] . Modeling with graph neural networks (GNN) is a new research direction. A graph is a natural way to represent the structure of a molecule, in which each atom or residue can be set as a node and interactions between atoms can be treated as edges [ 13 , 14 , 15 , 16 ] . Despite progress, critical challenges persist. First, the limited availability of high-quality experimental affinity data demands models with high data efficiency, which most existing DL-based PLA approaches rarely address [ 17 ] . Second, poor cross-target generalization persists, particularly when deploying models across divergent protein families. This is reflected in model’s performance drops when applied to novel receptor classes beyond training domains [ 18 , 19 , 20 ] . Thirdly, many models overlook geometric invariance in their input representations. The lack of translational and rotational invariance in binding affinity predictions leads to inconsistent and unstable performance. Some existing works focus only on E(3) invariance, which fails to properly account for molecular chirality since E(3) network also treat reflection as invariance [ 21 , 22 ] . To address these gaps, we propose IPBind, a efficient model that predicts protein-ligand binding affinity through Interatmoic Potential modeling. Our key contributions are: (1): IPBind enables efficient training while achieving better generalization to unseen proteins. Additionally, it offers intuitive interpretability of predictions. (2) IPBind is SE(3)-invariant, making it more aligned with real-world physics. (3): Our model demonstrates robust performance across predicted structures as input, extending predictive capabilities beyond existing methods. These characteristics highlight the potential of the proposed IPBind for real-world drug discovery pipelines. II MATERIALS AND METHODS Our objective is to predict the binding affinity of protein-ligand complexes from their structures. This is a regression task where the labels represent continuous binding affinity values. II-A Overview of IPBind We propose IPBind, a geometric deep learning model for predicting protein-ligand binding affinity. Our approach is inspired by the principle of machine-learning interatomic potentials, where the total energy of a molecular system is approximated as the sum of individual atomic contributions [ 23 , 24 , 25 , 26 ] . we derive the binding affinity by quantifying the sum of energy difference of each atom before and after binding. Figure 1 illustrates the overall workflow of IPBind. The model takes protein-ligand complex as input. In order to make a balance between focusing on protein-ligand interactions and computational efficiency, we first cropped the protein pocket to concentrate on the most critical interaction sites, which was defined as maximum to the closest 50 residues to ligand’s heavy atoms, and we preserve all heavy atoms of selected residues and ligand. The model consists of three main modules: preprocessing, massage passing, and prediction. To address the challenge of ensuring SE(3)-invariance for 3D molecules while avoiding the computational complexity, we employ frame averaging (FA) [ 27 , 28 ] . FA introduces symmetry awareness to any architecture by averaging its outputs over a carefully selected subset of group elements, as frames. In the preprocessing module, three graphs were created for encoder models based on the input structure: the bound complex, the protein, and the ligand. We then create frames for the coordinates of each input. In the Encoder module, message passing is employed to capture interatomic interactions and iteratively update atomic representations. The prediction module leverages encoder-generated atomic embeddings to predict the energy contribution of each atom in both its unbound and bound states. To ensure SE(3)-invariance, these predictions are averaged over the output of each frame. The final binding affinity is calculated as the sum of energy differences between the bound complex and unbound components. II-B Preprocessing module Frame averaging Since our goal is to predict binding affinity—-a scalar quantity—-we focus specifically on ensuring output invariance under SE(3) transformations. We adopt the Frame Averaging (FA) transformation to canonical plane to enable the output of geometric graph neural networks to be SE(3)-invariance [ 27 ] . For molecular systems with atom positions X\in\mathbb{R}^{n\times 3} , we define frames via principal component analysis (PCA): 1. Compute centroid and covariance matrix: \displaystyle t \displaystyle=\frac{1}{n}X^{\top}\mathbf{1}\in\mathbb{R}^{3}. (1) \displaystyle\Sigma \displaystyle=(X-\mathbf{1}t^{\top})^{\top}(X-\mathbf{1}t^{\top}). (2) 2. Solve eigenvalue problem \Sigma u=\lambda u to obtain eigenvectors u_{1},u_{2},u_{3} with \lambda_{1}>\lambda_{2}>\lambda_{3} 3. Define 4 frames for achieving